Aloha Medicinals Announces Construction of Second Nanoparticle Device
Aloha Medicinals (Carson City, NV) announced the construction of a second proprietary nanoparticle manufacturing device, the company said on January 6. Aloha first introduced nano-sized medicinal mushroom products in early 2008.
Aloha Medicinals (Carson City, NV) announced the construction of a second proprietary nanoparticle manufacturing device, the company said on January 6. Aloha first introduced nano-sized medicinal mushroom products in early 2008.
“Nanoparticles, sometimes called sub-micronized particles, those of 1 microns or less in size, demonstrate remarkable ability to increase the body’s ability to absorb nutrients and medicines,” said John Holliday, president and chief scientific officer of Aloha Medicinals.
“The smaller the particle size, the more efficient the nutrient or drug becomes. That means that ultimately less of the drug is required to obtain a therapeutic affect, which in turn means that medicines not only cost less, but absorption is quicker and the potential for side-effects is minimized.”
The technology uses jets of high pressure gas to grind the particles down to sizes small enough to pass through the skin. In order to prevent heat from building up, the gas jets are fed through a specially designed nozzle that creates cold rather than heat. The gas jets stream into the manufacturing chamber at temperatures of 30 degrees below zero.
Roger Scott, the Aloha’s CEO said that the new technology opens opportunities in the areas of dietary supplements, OTC and prescription drugs, cosmetics and liquids.
“The micronized particles of insoluble material are so fine they appear to become soluble, allowing them to be inserted in liquids and not fall to the bottom of the bottle,” said Scott.
“This technology gives us the ability to produce novel new dosage forms that will make it more convenient and less expensive for people to stay well.”
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The 2023 Supplement Consumer: Immune Health and Beyond
April 19th 2024Did you know two-out-of-three U.S. supplement consumers say their immune health has become more important to them, yet only 38% would describe their immune health as “very healthy?” There’s an opportunity to meet consumers in their growing desire to live healthier lifestyles and help them redefine resilience. IMMUSETM is the universal postbiotic for year-round immune support. Unlock exclusive consumer insights and discover the formulation opportunities with IMMUSETM with this consumer research.
